SOURCE: Streetwise Reports

Streetwise Reports

July 17, 2017 15:07 ET

UPDATE - Streetwise Reports Examines How One Multifaceted Biotech Company Began Trading on Canadian Securities Exchange

SAN FRANCISCO, CA--(Marketwired - July 17, 2017) - A Vancouver-based biotech firm that aims to become the first preventative medicine company commenced trading on the Canadian Securities Exchange July 14.

Included in this article is: PreveCeutical Medical Inc. (CSE: PREV) (CSE: PREV.CN) (CNSX: PREV)

Shares of PreveCeutical Medical Inc. began trading on the Canadian Securities Exchange on July 14 under the symbol PREV. The company, named after its focus on preventative nutraceuticals, has a pipeline that includes a cannabidiol-infused soluble gel delivery system and a dual-gene therapy targeting obesity and diabetics.

In April, PreveCeutical formed a partnership with UniQuest Pty Limited at Queensland University in Australia. According to the company, UniQuest will conduct a research program "for the extraction, formulation and ex vivo evaluation of cannabinoids (CBDs) for local/direct nose-to-brain delivery via Sol-Gels. UniQuest is the main commercialisation company for The University of Queensland."

"Due to increasing evidence of the clinical benefits presented by CBDs, and recent legalisation of 'medical marijuana' across a number of jurisdictions, PMI is seeking development and evaluation of translatable formulations for central nervous system (CNS) delivery of CBDs, for which, soluble gels (sol-gels) present an ideal platform for achieving this aim, being in-solution upon administration, and rapidly gelling upon contact with mucosal tissue, paving the way for safer, reliable drug delivery for agents, such as CBDs that are rapidly metabolised, or that would benefit from direct nose-to-brain CNS delivery to provide clinical benefit," the company noted.

Continue reading this article: Multifaceted Biotech Company Poised to Begin Trading on Canadian Securities Exchange

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

DISCLOSURES:

The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Streetwise Reports does not accept stock in exchange for its services. Click here for important disclosures about sponsor fees. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers.

Please see the end of the article for the complete disclosures: Multifaceted Biotech Company Poised to Begin Trading on Canadian Securities Exchange

Contact Information

  • Contact Information:
    Carrie Beal Amaro
    Associate Publisher
    Email contact